Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Follicum AB and University of Bradford disclose compounds for skin and hair disorders

May 24, 2022

Idorsia Pharmaceuticals patents new LGALS3 inhibitors

May 24, 2022

Shenzhen Chipscreen Biosciences divulges PD-1/PD-L1 and/or CD80/PD-L1 interaction inhibitors

May 24, 2022

New PROTACs developed by Luzhou Baicaotang Chinese Traditional Medicine

May 23, 2022

Shanghai Meizer Pharmaceuticals presents new PTPN11 inhibitors

May 23, 2022

Shanghai Meizer Pharmaceuticals identifies new PROTACs for cancer

May 23, 2022

Chinese researchers disclose BCL2 mutant inhibitors

May 23, 2022

Sichuan Kelun-Biotech Biopharmaceutical patents Raf/Ras kinase inhibitors

May 23, 2022

Chulalongkorn University presents compounds for treating hepatitis B virus infections

May 20, 2022

Spectrum Pharmaceuticals divulges G12C mutant GTPase KRAS inhibitors

May 20, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Ontrack Therapeutics divulges compounds for neurodegenerative diseases
BioWorld Science
Ontrack Therapeutics Ltd. has reported new heterotricyclic compounds potentially useful for the treatment of neurodegenerative diseases.
Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists
BioWorld Science
Reunion Neuroscience Inc. has identified new 5-HT2A receptor partial agonists and/or 5-HT2B receptor antagonists potentially useful for the treatment of...